Prostate Cancer (Hb 2011). Questo articolo non è disponibile.Prostate Cancer (Hb 2011)

<p>This issue of Radiation Medicine Rounds examines the latest advances in the use of radiation medicine in treatment of prostate cancer Prostate cancer is the most common cancer in males and radiation therapy is a major tool in the management of the disease. This issue of Radiation Medicine Rounds includes reviews of all major recent advances in treatment of favorable, intermediate and high-risk prostate cancer as well as newer modalities such as brachytherapy, stereotactic body radiation therapy, and proton beam radiotherapy. Articles also review current knowledge in the areas of new biomarkers, risk stratification, and risk stratification. This issue of RMR will provide the practitioner with a full current overview of the present best practices and recent research in management of this complex and challenging disease. </p><b>Radiation Medicine Rounds features:</b> <p> <ul> <li>In-depth, up-to-date expert reviews and analysis of major new developments in all areas of Radiation Medicine <li>Each issue edited by an authority in that subject area <li>Each issue focused on a single major topic in Radiation Medicine, providing coverage of advances in radiation science, radiation medicine technology, radiation medicine practice, and assessment of recent quality and outcome studies </li></li></li></ul> <p></p>"</p>

Srinivasan Vijayakumar, MD Department Chair and Professor, Department of Radiation Oncology, University of Mississippi Medical Center. Allen Chen, MDAssistant Professor and Director, Residency and Fellowship Training Program, Department of radiation Oncology, UC Davis Medical Center. Charles Thomas, Jr., MD, Chairman, Department of Radiation Medicine, Oregon Health and Science University.